Generic drug ETF ailing despite political focus on high drug prices

NEW YORK (Reuters) - Calls in the U.S. presidential campaign to cut pharmaceutical prices are not helping to revive a barely two-month-old exchange-traded fund that invests in shares of generic drugmakers.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro